Suppr超能文献

加速表达 Myc 靶基因 Mina53 与侵袭性肝细胞癌。

Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma.

机构信息

Department of Pathology, Kurume University School of medicine, Asahi-machi, Kurume, Fukuoka.

出版信息

Hepatol Res. 2010 Apr;40(4):330-6. doi: 10.1111/j.1872-034X.2009.00604.x. Epub 2010 Jan 11.

Abstract

AIM

Expressions of the myc target genes Mina53 and mimitin are high in esophageal squamous cell carcinoma and colon cancer, and their relationship to cell proliferation and patient prognosis has been reported. Because c-myc gene expression is closely related to hepatocellular carcinoma (HCC) growth or formation and/or maintenance, we examined the Mina53 and mimitin expressions in HCC.

METHODS

Surgically resected 53 HCC tissues were immunohistochemically examined for Mina53 and mimitin expressions and their relationship to clinicopathological factors.

RESULTS

Diffuse Mina53 expression was observed in the nuclei of cancer cells in the tumor nodule, but was often strong at the periphery of tumor nodules. Diffuse or scattered expression of mimitin was observed in the cytoplasm of HCC cells in tumor nodules. Mina53 expression was higher in poorly differentiated HCC than in well-differentiated HCC, and significant relationship to histological grade was observed. The cases with a high Mina53 expression also had a high expression of a proliferation marker MIB-1. This suggested the involvement of Mina53 in cell proliferation. Mina53 expression was high in the tumors of >2 cm of diameter than in </=2 cm (P < 0.01). Mimitin expression tended to be high in tumors of >2 cm, but no significant relationship was observed either to histological grade, MIB-1 expression, or the other clinicopathologic factors.

CONCLUSIONS

Our findings suggested that Mina53 expression is accelerated in HCC with a lower histological grade, with cell proliferation capability, or with a larger diameter, and Mina53 is related to biological malignancy of HCC.

摘要

目的

Mina53 和 mimitin 的 myc 靶基因表达在食管鳞状细胞癌和结肠癌中较高,其与细胞增殖和患者预后的关系已有报道。由于 c-myc 基因表达与肝细胞癌(HCC)的生长或形成和/或维持密切相关,我们研究了 Mina53 和 mimitin 在 HCC 中的表达。

方法

对 53 例手术切除的 HCC 组织进行免疫组织化学检查,以检测 Mina53 和 mimitin 的表达及其与临床病理因素的关系。

结果

肿瘤结节中癌细胞的细胞核中可见弥漫性 Mina53 表达,但肿瘤结节的外围常较强。肿瘤结节中 HCC 细胞的细胞质中可见弥漫性或散在性 mimitin 表达。低分化 HCC 的 Mina53 表达高于高分化 HCC,且与组织学分级有显著关系。高 Mina53 表达的病例也有较高的增殖标志物 MIB-1 表达。这表明 Mina53 参与了细胞增殖。直径>2cm 的肿瘤中 Mina53 表达较高,而直径≤2cm 的肿瘤中 Mina53 表达较低(P<0.01)。Mimitin 表达倾向于在直径较大的肿瘤中较高,但与组织学分级、MIB-1 表达或其他临床病理因素均无显著关系。

结论

我们的研究结果表明,Mina53 表达在组织学分级较低、具有增殖能力或直径较大的 HCC 中加速,并且 Mina53 与 HCC 的生物学恶性程度有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验